What is it about?
Verapamil is an excellent drug used for the medication of hypertension and trandolapril. It is an angiotensin-converting-enzyme inhibitor. Hence, it is an interesting method to develop a novel and reliable MS/UPLC strategy for the simultaneous development of verapamil and trandolapril.
Featured Image
Why is it important?
This research study aims to develop a new, rapid, and sensitive UPLC-MS/MS method for the simultaneous estimation of verapamil and trandolapril in rat plasma using D6- verapamil and D6-trandolapril.
Read the Original
This page is a summary of: Development and Validation of a UPLC-MS/MS Method for the Simultaneous
Determination of Verapamil and Trandolapril in Rat Plasma: Application
to a Pharmacokinetic Study, Current Pharmaceutical Analysis, March 2022, Bentham Science Publishers,
DOI: 10.2174/1573412917666210302145711.
You can read the full text:
Contributors
The following have contributed to this page
